238 related articles for article (PubMed ID: 1771591)
1. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection.
Barr M; Cohen MM
Teratology; 1991 Nov; 44(5):485-95. PubMed ID: 1771591
[TBL] [Abstract][Full Text] [Related]
2. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
Quan A
Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
[TBL] [Abstract][Full Text] [Related]
3. Effect of ACE inhibition on the fetal kidney: decreased renal blood flow.
Martin RA; Jones KL; Mendoza A; Barr M; Benirschke K
Teratology; 1992 Oct; 46(4):317-21. PubMed ID: 1412062
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme inhibitor fetopathy.
Hegde AU; Parekji S; Ali US; Mehta KP
Indian Pediatr; 1999 Jan; 36(1):79-82. PubMed ID: 10709127
[No Abstract] [Full Text] [Related]
5. Angiotensin-converting enzyme inhibitor fetopathy.
Pryde PG; Sedman AB; Nugent CE; Barr M
J Am Soc Nephrol; 1993 Mar; 3(9):1575-82. PubMed ID: 8507813
[TBL] [Abstract][Full Text] [Related]
6. Teratogen update: angiotensin-converting enzyme inhibitors.
Barr M
Teratology; 1994 Dec; 50(6):399-409. PubMed ID: 7778045
[TBL] [Abstract][Full Text] [Related]
7. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):240-2. PubMed ID: 9082178
[TBL] [Abstract][Full Text] [Related]
8. Recognition and management of angiotensin converting enzyme inhibitor fetopathy.
Sedman AB; Kershaw DB; Bunchman TE
Pediatr Nephrol; 1995 Jun; 9(3):382-5. PubMed ID: 7632538
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibitors in pregnancy--how to avoid the sting in the tail.
Opie LH
S Afr Med J; 1996 Apr; 86(4):326-7. PubMed ID: 8693361
[No Abstract] [Full Text] [Related]
10. [Teratogenic effects of ACE-inhibitors and angiotensin II receptor antagonists].
Sørensen AM; Christensen S; Jonassen TE; Andersen D; Petersen JS
Ugeskr Laeger; 1998 Mar; 160(10):1460-4. PubMed ID: 9520613
[TBL] [Abstract][Full Text] [Related]
11. Congenital renal tubular dysplasia and skull ossification defects similar to teratogenic effects of angiotensin converting enzyme (ACE) inhibitors.
Kumar D; Moss G; Primhak R; Coombs R
J Med Genet; 1997 Jul; 34(7):541-5. PubMed ID: 9222960
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors.
Brent RL; Beckman DA
Teratology; 1991 Jun; 43(6):543-6. PubMed ID: 1882342
[No Abstract] [Full Text] [Related]
13. ACE inhibitor fetopathy: a case series and survey of opinion amongst New Zealand paediatricians, obstetricians, neonatologists, and nephrologists.
Deva M; Kara T
N Z Med J; 2012 Sep; 125(1361):51-61. PubMed ID: 22960716
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors.
Piper JM; Ray WA; Rosa FW
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):429-32. PubMed ID: 1495700
[TBL] [Abstract][Full Text] [Related]
15. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure.
Chisholm CA; Chescheir NC; Kennedy M
Am J Perinatol; 1997 Oct; 14(9):511-3. PubMed ID: 9394157
[TBL] [Abstract][Full Text] [Related]
16. Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists.
Vendemmia M; Garcia-Méric P; Rizzotti A; Boubred F; Lacroze V; Liprandi A; Simeoni U
J Matern Fetal Neonatal Med; 2005 Aug; 18(2):137-40. PubMed ID: 16203601
[TBL] [Abstract][Full Text] [Related]
17. Neonatal anuria with maternal angiotensin-converting enzyme inhibition.
Rosa FW; Bosco LA; Graham CF; Milstien JB; Dreis M; Creamer J
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):371-4. PubMed ID: 2761913
[TBL] [Abstract][Full Text] [Related]
18. Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: Role of the Renin-Angiotensin system.
Lacoste M; Cai Y; Guicharnaud L; Mounier F; Dumez Y; Bouvier R; Dijoud F; Gonzales M; Chatten J; Delezoide AL; Daniel L; Joubert M; Laurent N; Aziza J; Sellami T; Amar HB; Jarnet C; Frances AM; Daïkha-Dahmane F; Coulomb A; Neuhaus TJ; Foliguet B; Chenal P; Marcorelles P; Gasc JM; Corvol P; Gubler MC
J Am Soc Nephrol; 2006 Aug; 17(8):2253-63. PubMed ID: 16790508
[TBL] [Abstract][Full Text] [Related]
19. Taking ACE inhibitors during pregnancy. Is it safe?
Ratnapalan S; Koren G
Can Fam Physician; 2002 Jun; 48():1047-9. PubMed ID: 12113190
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-II-receptor inhibitors in pregnancy.
Lambot MA; Vermeylen D; Noël JC
Lancet; 2001 May; 357(9268):1619-20. PubMed ID: 11386314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
